Activation of metabotropic glutamate receptor 5 has direct excitatory effects and potentiates NMDA receptor currents in neurons of the subthalamic nucleus

Journal of Neuroscience

Volumn 20, Issue 21, 2000, Pages 7871-7879

  Awad, H ^a   Hubert, G W ^a   Smith, Y ^a   Levey, A I ^a   Conn, P J ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Basal ganglia; Burst firing; Metabotropic glutamate receptor; MGluR1; MGluR5; NMDA receptor; Parkinson's disease; Subthalamic nucleus

Indexed keywords

METABOTROPIC RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; RECEPTOR SUBTYPE;

ANIMAL TISSUE; ARTICLE; BASAL GANGLION; GABAERGIC TRANSMISSION; IMMUNOHISTOCHEMISTRY; MEMBRANE CURRENT; MEMBRANE DEPOLARIZATION; MOTOR PERFORMANCE; NONHUMAN; PARKINSON DISEASE; POSTSYNAPTIC INHIBITION; PRIORITY JOURNAL; RAT; RECEPTOR UPREGULATION; SECOND MESSENGER; SUBTHALAMIC NUCLEUS; SYNAPTIC TRANSMISSION;

EID: 0034332480     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.20-21-07871.2000     Document Type: Article

References (63)

1. Excitation of rat subthalamic nucleus neurones in vitro by activation of a group I metabotropic glutamate receptor
2. Light microscopic analysis of Golgi-impregnated rat subthalamic nucleus neurons
3. The functional anatomy of basal ganglia disorders
4. Striatal and nigral neuron subpopulations in rigid Huntington's disease: Implications for the functional anatomy of chorea and rigidity-akinesia
5. A novel class of antagonists for metabotropic glutamate receptors, 7-(hydroxyimino)cyclopropchromen-1a-carboxylates
6. Lesion of the subthalamic nucleus for the alleviation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism in the primate
7. Reversal of rigidity and improvement in motor performance by subthalamic high-frequency stimulation in MPTP-treated monkeys
8. Single unit recordings of subthalamic nucleus and pars reticulata of substantia nigra in akineto-rigid parkinsonian patients
9. Reversal of experimental parkinsonism by lesions of the subthalamic nucleus
10. The primate subthalamic nucleus II. Neuronal activity in the MPTP model of parkinsonism
11. Subthalamic nucleus neurons switch from single-spike activity to burst-firing mode
12. Mechanisms underlying spontaneous oscillation and rythmic firing in rat subthalamic neurons
13. Anti-hyperalgesic effects of the novel metabotropic glutamate receptor 5 antagonist, 2-methyl-6-(phenylethynyl)-pyridine, in rat models of inflammatory pain
14. Distribution and developmental regulation of metabotropic glutamate receptor 7a in rat brain
15. Immunohistochemical localization of subtype 4a metabotropic glutamate receptor in the rat and mouse basal ganglia
16. Activation of group II metabotropic glutamate receptors inhibits synaptic excitation of the substantia nigra pars reticulata
17. Heterogeneity of metabotropic glutamate receptors in the striatum: Electrophysiological evidence
18. Expression and coupling to polyphosphoinositide hydrolysis of group I metabotropic glutamate receptors in early postnatal and adult rat brain
19. Metabotropic glutamate receptors modulate N-methyl-D-aspartate receptor function in neostriatal neurons
20. Pharmacology and functions of metabotropic glutamate receptors
21. 2+-activated non-specific cationic current in CA1 hippocampal neurons
22. Actions of D and L forms of 2-amino-5-phosphonovalerate and 2-amino-4-phosphonobutyrate in the cat spinal cord
23. Primate models of movement disorders of basal ganglia origin
24. 2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist
25. Multiple presynaptic metabotropic glutamate receptors modulate excitatory and inhibitory synaptic transmission in hippocampal area CA1
26. + current by metabotropic glutamate and muscarinic receptors in rat CA3 cells: Mediation by G-proteins
27. Activation of a nonselective cationic conductance by metabotropic glutamatergic and muscarinic agonists in CA3 pyramidal neurons of the rat hippocampus
28. Subthalamotomy in parkinsonian monkeys. Behavioural and biochemical analysis
29. Increased subthalamic neuronal activity after nigral dopaminergic lesion independent of disinhibition via the globus pallidus
30. Subthalamic nucleus cell firing in the 6-OHDA-treated rat: Basal activity and response to haloperidol
31. Subsynaptic localization of group I metabotropic glutamate receptors (mGluRs) in the ventral midbrain of rats
32. A Golgi study on the subthalamic nucleus of the cat
33. Intrastriatal and intrasubthalamic stimulation of metabotropic glutamate receptors: A behavioral and Fos immunohistochemical study
34. 14C]-2-deoxyglucose autoradiographic study
35. 1S,3R-ACPD has cataleptogenic effects and reverses MK-801- and less pronounced, D,L-amphetamine-induced locomotion
36. The mGluR group II agonist (2S,3S,4S)-alpha-carboxycyclopropyl-glycine induces catalepsy in the rat, which is pronouncedly antagonised by dizocilpine and D,L-amphetamine
37. Pathogenesis of Tourette's syndrome
38. Bilateral subthalamic nucleus stimulation for severe parkinson's disease
39. Effect on parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation
40. CPCCOEt, a noncompetitive metabotropic glutamate receptor 1 antagonist, inhibits signaling without affecting glutamate binding
41. 1 receptor antagonist activity
42. Metabotropic glutamate receptors inhibiting excitatory synapses in the CA1 area of rat hippocampus
43. Direct excitation of GABAergic projection neurons of the rat substantia nigra pars reticulata by activation of the mGluR1 metabotropic glutamate receptor
44. Potential antiparkinsonian actions of metabotropic glutamate receptors in the substantia nigra pars reticulata
45. Design, synthesis, and pharmacological characterization of (+)-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid (LY354740): A potent, selective, and orally active group 2 metabotropic glutamate receptor agonist possessing anticonvulsant and anxiolytic properties
46. Enhancement of NMDA responses by group I metabotropic glutamate receptor activation in striatal neurones
47. A basal ganglia pacemaker formed by the subthalamic nucleus and external globus pallidus
48. Pharmacological treatment of Parkinson's disease
49. G protein-coupled receptors mediate a fast excitatory postsynaptic current in CA3 pyramidal neurons in hippocampal slices
50. Immunohistochemical study of two phosphoinositide-linked metabotropic glutamate receptors (mGluR1a and mGluR5) in the cat visual cortex before, during, and after the peak of the critical period for eye-specific conditions
51. Differential loss of striatal projection neurons in Huntington's disease
52. Characteristics of neuronal activity in the subthalamic nucleus (STN) and substantia nigra pars reticulata (SNr) in Parkinson's disease (PD)
53. Switch from facilitation to inhibition of excitatory synaptic transmission by group I mGluR desensitization
54. Distribution of metabotropic glutamate receptor mGluR5 immunoreactivity in rat brain
55. Metabotropic glutamate receptor 5 is a disulfide-linked dimer
56. Intrastriatal injection of a selective metabotropic excitatory amino acid receptor agonist induces contralateral turning in the rat
57. Metabotropic glutamate receptor activation produces extrapyramidal motor system activation that is mediated by striatal dopamine
58. 3,3-Dihydroxyphenylglycine is a highly selective agonist for phosphoinositide-linked metabotropic glutamate receptors in the rat hippocampus
59. Immunohistochemical localization of a metabotropic glutamate receptor, mGluR5, in the rat brain
60. Localization of mGluR1a-like immunoreactivity and mGluR5-like immunoreactivity in identified populations of striatal neurons
61. Metabotropic glutamate receptor mRNA expression in the basal ganglia of the rat
62. Immunohistochemical localization of metabotropic glutamate receptors mGluR1a and mGluR2/3 in the rat basal ganglia
63. Physiology of the basal ganglia and pathophysiology of movement disorders of basal ganglia origin